Joint Formulary & PAD

Epoetin zeta - Anaemia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous injection (IV)
  • Subcutaneous injection (sc)
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important

Symptomatic anaemia in MDS or chronic renal failure, adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Epoetin zeta
Indication :
Anaemia
Group Name :
Keywords :
Brand Names Include :
Retacrit
Important Information :

Heamatology team only. 
NOT for dialysis-induced anaemia - this is not commissoned from any Surrey Heartlands Trusts. 

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Epoetin zeta is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Anaemia.

Committee Recommendations (1)

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.